Pascal Libert
Président chez Investipharm Belgium NV
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Anne Lhote | F | 55 |
Objectif Pharma
Objectif Pharma Wholesale DistributorsDistribution Services Objectif Pharma is a French company that specializes in intermediaries for the sale of specific products. Thierry Chapusot has been the CEO of the private company since 2009.
Alpha Finance Répartition
Stallion Management
Investipharm Belgium NV
Investipharm France
| 15 ans |
William Le Bellego | M | 55 |
Objectif Pharma
Objectif Pharma Wholesale DistributorsDistribution Services Objectif Pharma is a French company that specializes in intermediaries for the sale of specific products. Thierry Chapusot has been the CEO of the private company since 2009.
Société d'Exploitation de Marques et Services
| 15 ans |
Thierry Chapusot | M | 65 |
Société d'Exploitation de Marques et Services
Objectif Pharma
Objectif Pharma Wholesale DistributorsDistribution Services Objectif Pharma is a French company that specializes in intermediaries for the sale of specific products. Thierry Chapusot has been the CEO of the private company since 2009. | 15 ans |
Philippe Champigneulle | M | - |
DNCA Finance SA
DNCA Finance SA Investment ManagersFinance DNCA Finance SA is the asset management subsidiary of Natixis Investment Managers SA, ultimately held by BPCE SA in France. The firm is headquartered in Paris and was founded in 2000. In 2007, they created a management company in Luxembourg to manage and market an umbrella SICAV fund called DNCA Invest which aims to replicate certain funds created under French law and to acquire new products. DNCA Invest is the flagship for the firm's European expansion. DNCA Finance is a socially responsible investor and integrates environmental, social and societal aspects into its analysis. | 19 ans |
Daniel Antoine | M | 72 |
Objectif Pharma
Objectif Pharma Wholesale DistributorsDistribution Services Objectif Pharma is a French company that specializes in intermediaries for the sale of specific products. Thierry Chapusot has been the CEO of the private company since 2009.
Investipharm France
| 12 ans |
Hugues Moreaux | M | 71 |
Objectif Pharma
Objectif Pharma Wholesale DistributorsDistribution Services Objectif Pharma is a French company that specializes in intermediaries for the sale of specific products. Thierry Chapusot has been the CEO of the private company since 2009.
Investipharm France
| 15 ans |
Emilie Lecomte | M | 45 |
Objectif Pharma
Objectif Pharma Wholesale DistributorsDistribution Services Objectif Pharma is a French company that specializes in intermediaries for the sale of specific products. Thierry Chapusot has been the CEO of the private company since 2009. | 10 ans |
Marc Hoeschen | M | - |
Investipharm Belgium NV
| 13 ans |
Laurent Turquier | M | - |
Investipharm Belgium NV
| 13 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Mathieu | M | 75 |
Stallion Investment
Alpha Finance Répartition
Stallion Management
Coopérative CIP
| 4 ans |
Bruno Francois Jules Angelici | M | 77 |
University of Reims Champagne-Ardenne
| 3 ans |
Arielle Lévi | F | - |
DNCA Finance SA
DNCA Finance SA Investment ManagersFinance DNCA Finance SA is the asset management subsidiary of Natixis Investment Managers SA, ultimately held by BPCE SA in France. The firm is headquartered in Paris and was founded in 2000. In 2007, they created a management company in Luxembourg to manage and market an umbrella SICAV fund called DNCA Invest which aims to replicate certain funds created under French law and to acquire new products. DNCA Invest is the flagship for the firm's European expansion. DNCA Finance is a socially responsible investor and integrates environmental, social and societal aspects into its analysis. | - |
Remy M. Gicquel | M | - |
DNCA Finance SA
DNCA Finance SA Investment ManagersFinance DNCA Finance SA is the asset management subsidiary of Natixis Investment Managers SA, ultimately held by BPCE SA in France. The firm is headquartered in Paris and was founded in 2000. In 2007, they created a management company in Luxembourg to manage and market an umbrella SICAV fund called DNCA Invest which aims to replicate certain funds created under French law and to acquire new products. DNCA Invest is the flagship for the firm's European expansion. DNCA Finance is a socially responsible investor and integrates environmental, social and societal aspects into its analysis. | 6 ans |
Jean-Pierre Dosdat | M | 60 |
Objectif Pharma
Objectif Pharma Wholesale DistributorsDistribution Services Objectif Pharma is a French company that specializes in intermediaries for the sale of specific products. Thierry Chapusot has been the CEO of the private company since 2009. | 11 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
France | 12 | 85,71% |
Belgique | 4 | 28,57% |
Luxembourg | 2 | 14,29% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Pascal Libert
- Réseau Personnel